Incident wheeze | Incident wheeze without a cold | Incidence of diagnosed asthma | |||||
---|---|---|---|---|---|---|---|
% (n/N)* | Adjusted IRR(95% CI)† | % (n/N)* | Adjusted IRR(95% CI)† | % (n/N)* | Adjusted IRR(95% CI)† | ||
n, cases; N, total of exposed; IRR, incidence risk ratio; CI, confidence interval. | |||||||
*Population comprises subjects without missing values for the outcome, exposure, and confounding variables. | |||||||
†All models adjusted for sex, age, and study centre (for further detail see Methods). | |||||||
‡Additionally adjusted for duration of ETS exposure at follow up. | |||||||
¶Additionally adjusted for ETS exposure at home at baseline. | |||||||
§Additionally adjusted for atopy. | |||||||
**Additionally adjusted for intensity of active smoking and duration of active smoking. | |||||||
ETS exposure at home at baseline‡ | |||||||
No | 7.8 (96/1234) | 2.8 (33/1171) | 1.2 (14/1136) | ||||
Yes | 9.5 (57/597) | 1.22 (0.87 to 1.72) | 3.9 (22/562) | 1.39 (0.79 to 2.46) | 2.2 (12/534) | 2.00 (0.84 to 4.76) | |
ETS exposure at follow up | |||||||
No | 8.0 (71/888) | 3.3 (20/599) | 1.4 (12/841) | ||||
Yes | 8.8 (84/952) | 1.04 (0.74 to 1.46)¶ | 3.7 (25/677) | 1.19 (0.68 to 2.10)§ | 1.7 (15/888) | 1.25 (0.57 to 2.73)** | |
Duration of ETS exposure at follow up (h/day) | |||||||
Never | 8.0 (70/877) | 3.0 (25/832) | 1.5 (12/809) | ||||
⩽1 | 7.0 (28/399) | 0.88 (0.58 to 1.34) | 2.6 (10/381) | 0.88 (0.43 to 1.82) | 1.4 (5/369) | 0.93 (0.33 to 2.64) | |
1–5 | 10.5 (48/459) | 1.31 (0.92 to 1.86) | 4.0 (17/428) | 1.35 (0.74 to 2.48) | 2.2 (9/406) | 1.53 (0.63 to 3.70) | |
>5 | 8.1 (14/172) | 1.01 (0.58 to 1.77) | 3.7 (6/164) | 1.24 (0.52 to 2.97) | 0.6 (1/155) | 0.45 (0.05 to 3.75) |